Nautilus Biotechnology, Inc. (NAUT) has a market capitalization of $387.29M and trades at $3.06. The 52-week range is 0.62-4.31.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.5, Earnings Per Share (EPS) of $-0.47.
The stock has a beta of 0.99, operates in the Healthcare sector.
